
PROGRAM
Coming soon
REGISTRATION
Coming soon
SUBMISSION
Coming soon


KEY DATES
OPEN REGISTRATION
2ND JUNE 2025
OPEN SUBMISSION
APRIL 2025
END OF SUBMISSION
NOVEMBER 2025

Join Us for the IFCPC Paris 2026 World Congress!
Dear Colleagues, Dear Friends,
The International Federation for Cancer Prevention and Colposcopy (IFCPC) unites nearly 50 national societies from all over the world, each working towards the prevention, screening, and management of HPV-induced lesions.
While our approaches may vary due to differences in healthcare systems, social structures, and cultural perspectives, we share a common goal: reducing the burden of HPV-related diseases.
With nearly 700,000 HPV-induced cancers diagnosed each year—including 500,000 cases of cervical cancer, as well as vaginal, vulvar, anal, and ENT cancers—our fight remains critical.
To advance this mission, we must come together, exchange ideas, and share the latest scientific advancements.
The IFCPC Paris 2026 World Congress, held for the first time in France, will be the perfect opportunity to do just that.
Over three inspiring days from June 4 to 6, 2026, at the Palais des Congrès de Versailles, we will explore the most pressing issues in HPV research, prevention, and treatment.
Discussions will include:
- Primary prevention – How can we improve vaccination coverage? What are the latest vaccine protocols and innovations?
- Secondary prevention – The future of screening, virology, molecular genetics, and novel biomarkers.
- Diagnosis and treatment – Evaluating the best therapeutic approaches and emerging technologies such as AI.
- Tailored care : How should screening and follow-up be adapted for high-risk populations, immunocompromised patients, during pregnancy, and post-treatment monitoring?
- New frontiers – Understanding the role of the vaginal microbiota, optimal management of CIN2 and multifocal lesions, and screening strategies for anal lesions.
But IFCPC Paris 2026 will be much more than just a scientific conference. It will be a unique opportunity to connect, exchange, and learn in a warm and welcoming atmosphere.
With Versailles as our backdrop, we look forward to engaging discussions, memorable social events, and a truly exceptional experience in one of the world’s most iconic locations.
We can’t wait to welcome you to Paris, where we will learn, collaborate, and celebrate our shared commitment to advancing lower genital tract pathology and colposcopy.
Save the date – June 4-6, 2026 – and be part of this unforgettable event!
See you in Paris!
Jean-Luc Mergui IFCPC President

KEY DATES
OPEN REGISTRATION
2ND JUNE 2025
OPEN SUBMISSION
1ST APRIL 2025
END OF SUBMISSION
NOVEMBER 2025

Join Us for the IFCPC Paris 2026 World Congress!
Dear Colleagues, Dear Friends,
The International Federation for Cancer Prevention and Colposcopy (IFCPC) unites nearly 50 national societies from all over the world, each working towards the prevention, screening, and management of HPV-induced lesions.
While our approaches may vary due to differences in healthcare systems, social structures, and cultural perspectives, we share a common goal: reducing the burden of HPV-related diseases.
With nearly 700,000 HPV-induced cancers diagnosed each year—including 500,000 cases of cervical cancer, as well as vaginal, vulvar, anal, and ENT cancers—our fight remains critical.
To advance this mission, we must come together, exchange ideas, and share the latest scientific advancements.
The IFCPC Paris 2026 World Congress, held for the first time in France, will be the perfect opportunity to do just that.
Over three inspiring days from June 4 to 6, 2026, at the Palais des Congrès de Versailles, we will explore the most pressing issues in HPV research, prevention, and treatment.
Discussions will include:
- Primary prevention – How can we improve vaccination coverage? What are the latest vaccine protocols and innovations?
- Secondary prevention – The future of screening, virology, molecular genetics, and novel biomarkers.
- Diagnosis and treatment – Evaluating the best therapeutic approaches and emerging technologies such as AI.
- Tailored care : How should screening and follow-up be adapted for high-risk populations, immunocompromised patients, during pregnancy, and post-treatment monitoring?
- New frontiers – Understanding the role of the vaginal microbiota, optimal management of CIN2 and multifocal lesions, and screening strategies for anal lesions.
But IFCPC Paris 2026 will be much more than just a scientific conference. It will be a unique opportunity to connect, exchange, and learn in a warm and welcoming atmosphere.
With Versailles as our backdrop, we look forward to engaging discussions, memorable social events, and a truly exceptional experience in one of the world’s most iconic locations.
We can’t wait to welcome you to Paris, where we will learn, collaborate, and celebrate our shared commitment to advancing lower genital tract pathology and colposcopy.
Save the date – June 4-6, 2026 – and be part of this unforgettable event!
See you in Paris!
Jean-Luc Mergui IFCPC President
OUR SPONSORS







